https://www.marketscreener.com/quote/stock/UCB-5963/news/UCB-and-Daiichi-Sankyo-announce-Japanese-approval-of-lacosamide-brand-name-VIMPAT-as-adjunctiv-22624350/?utm_source=telegram&utm_medium=social&utm_campaign=share